Gabelli & Co Investment Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-633,700	Closed	-$1.56M	–	535
2020 Q4	$1.56M	Buy	+633,700	New	+$1.54M	0.24%	81

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Gabelli & Co Investment Advisers's PDLI Position: Q1 2021 in Review

Gabelli & Co Investment Advisers sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 633,700 shares — an estimated $1.56M sold.

Gabelli & Co Investment Advisers first reported a position in PDLI in Q4 2020 and held it in 1 quarter. The position peaked at $1.56M in Q4 2020. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

Gabelli & Co Investment Advisers reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 633,700 PDL BioPharma, Inc. shares in Q1 2021, an estimated $1.56M.
Gabelli & Co Investment Advisers first reported a position in PDL BioPharma, Inc. in Q4 2020 and held it in 1 quarter.
Gabelli & Co Investment Advisers's PDL BioPharma, Inc. position peaked at $1.56M in Q4 2020.
11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2021, filed 14 May 2021.